AngioDynamics, Inc. (ANGO) Revenue by Segment & Business Profile
Med Device was 50.7% of AngioDynamics, Inc.'s revenue across the 2 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
ANGOAngioDynamics, Inc.Follow ANGO — free
—
Price chart with a free account
- Market cap
- 520.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Jan, in 72 days
What the company does
AngioDynamics, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 2 business lines: Med Device (51%), Med Tech (49%). Trailing twelve-month revenue: $325.4 million as of 2026-08-31.
Roles we read
from the filings, not the sector label- Vascular / surgical devices
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| United States | 71M | 87.8% | +6.9% |
| Outside the US | 10M | 12.2% | +6.4% |
AngioDynamics, Inc. — questions
- What does AngioDynamics, Inc. do?
- AngioDynamics, Inc. is a medical instruments & supplies company in the healthcare sector. In its SEC filings it reports 2 business lines: Med Device (51%), Med Tech (49%). Trailing twelve-month revenue: $325.4 million as of 2026-08-31.
- How does AngioDynamics, Inc. make money?
- By the lines it reports in its SEC filings: Med Device 50.7%, Med Tech 49.3% of revenue.
Every figure on this page comes from AngioDynamics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.